Back to search
FDAFDA · Food and drugs·Recall number D-0858-2016

Sclerosol Intrapleural Aerosol (sterile talc powder), Intrapleural administration, 4 g Canister, Rx Only, Distributed by: Bryan Corporation, Woburn, MA 01801, USA, NDC 63256-100-30

Published June 1, 2016 · Recall initiated: April 28, 2016

Summary

FDA records drug Class II recall D-0858-2016, published June 1, 2016 and initiated April 28, 2016. Recalling firm: Lymol Medical; Status: Terminated; Reported quantity: 25,007 canisters; Lot: Lot #: 4L034, Exp. MAY 2017. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Defective Delivery System: Defective stem valve causes leakage of the propellant in the spray canister delivering no drug or an inadequate amount of the drug to be delivered.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Lymol Medical
Distributor
Nationwide
Lot
Lot #: 4L034, Exp. MAY 2017
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Sclerosol Intrapleural Aerosol (sterile talc powder), Intrapleural administration, 4 g Canister, Rx Only, Distributed by: Bryan Corporation, Woburn, MA 01801, USA, NDC 63256-100-30 recalled?

Yes. FDA published recall D-0858-2016 on June 1, 2016. Reported hazard: Defective Delivery System: Defective stem valve causes leakage of the propellant in the spray canister delivering no drug or an inadequate amount of the drug to be delivered.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail